Poolbeg Pharma PLC

NEW
OTCPK:POLBF (UK)   Ordinary Shares
$ 0.092 -0.024 (-20.36%) 11:08 PM EST
At Loss
P/B:
6.33
Market Cap:
$ 62.36M
Enterprise V:
$ 52.82M
Volume:
0
Avg Vol (2M):
11.45K
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
11.45K

Business Description

Description
Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field. The Company's main asset, POLB 001, has the potential to expand administration of cancer immunotherapies from centralised specialist cancer centres into community hospitals by making the treatments safer through the prevention of the life-threatening side effect, Cytokine Release Syndrome (CRS). The group is also advancing the development of a patient-friendly therapy for obesity with an oral encapsulated GLP-1, offering a differentiated approach within one of the world's markets. It is focused on partnering its high-value programmes that are targeting large markets and addressing critical unmet medical needs.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
0.87
Interest Coverage
No Debt
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year FCF Growth Rate
7.2
3-Year Book Growth Rate
-31.3

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
31.94
9-Day RSI
49.58
14-Day RSI
57.31
3-1 Month Momentum %
3.83
6-1 Month Momentum %
46.09
12-1 Month Momentum %
47.83

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
6.17
Quick Ratio
6.17
Cash Ratio
5.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-11.7
Shareholder Yield %
-8.35

Profitability Rank

Name Current Vs Industry Vs History
ROE %
-57.32
ROA %
-52.49
ROIC %
-246.55
3-Year ROIIC %
-1676.38
ROCE %
-60.35
Moat Score
5

GF Valueâ„¢

Poolbeg Pharma PLC Filings

Filing Date Document Date Form
No Filing Data

Poolbeg Pharma PLC Stock Events

Financials Calendars
Event Date Price ($)
Second quarter earnings results for 2026 2026-09-29 In 96 days
General meeting for 2025 2026-06-09 11:00 0.12 (+0.00%)
Annual report for 2025 2026-05-07 0.06 (+0.00%)
Fourth quarter earnings results for 2025 2026-04-28 0.06 (+0.00%)
Second quarter earnings results for 2025 2025-09-29 0.04 (+0.00%)
General meeting for 2024 2025-06-23 12:00 0.04 (+0.00%)
Annual report for 2024 2025-05-27 0.04 (+0.00%)
Fourth quarter earnings results for 2024 2025-05-20 0.12 (+0.00%)
Second quarter earnings results for 2024 2024-09-18 0.15 (+0.00%)
Show
Entries

Guru Commentaries on OTCPK:POLBF

No articles.

Articles on Poolbeg Pharma PLC

No articles.

Headlines

See More
  • 1
No news.
  • 1